Healthcare

This issue of Vital Signs, released on December 31, 2012, provides Frost & Sullivan's perspectives on the NYeC Digital Health Conference in New York during Q4 2012, including top takeaways from this event, as well as an overview of the conference, summary of an interview with NYeC, and a listing of companies comprising the inaugural class of the Ne...

This survey of 170 laboratory managers and researchers investigates budgets for these product categories: instruments, equipment, chemicals, life science reagents and kits, glassware, plasticware, and general laboratory supplies over the 2011-2013 period. Budgets for service and repair of instruments and equipment also are presented. Additionally,...

This research service is focused on the major bowel disorders and evaluates the market for oral and injectable prescription pharmaceuticals for the treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). This research service covers the U.S. market from 2009 to 2017, with 2011 as the base year. Included are products on t...

This research service considers products and companies in the bone grafts and bone graft substitutes market in the United States. This market expects to witness many technology advancements in the next decade. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the markets various segments...

This issue of Vital Signs, released on November 23, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

The primary objective of this research is to identify trends for quantitative polymerase chain reaction (PCR) techniques, specifically the use of nascent digital PCR (dPCR) technology in comparison with the mature real-time quantitative PCR (qPCR) technology. The research strives to compare differences of current and future use between qPCR and dPC...

This issue of Vital Signs, released on November 23, 2012, provides an insight in to breast screening against the backdrop of the recent changes in breast density reporting laws in the United States. Additionally, a company spotlight is provided for MinXray. Founded in 1967, MinXray, Inc. is a worldwide provider of transportable x-ray imaging eq...

This study provides a roadmap for understanding health information exchange. We provide an in-depth overview of the technical aspects of health information exchange (HIE), review major government initiatives driving health information exchange efforts across the U.S.,  define and describe the major market segments and subsegments, and look at rece...

This issue of Vital Signs, released on November 14, 2012, provides in-depth commentary on the 26th annual scientific meeting of the Association for Vascular Access (AVA) held October 16-19 in San Antonio, Texas.